For breast cancer, Irie et al. found that patients with Gal-9+ tumors had a more favorable DFS than patients with Gal-9- tumors, and lower Gal-9 expression could predict a relatively higher risk of metastasis [11]. The gene discussed is LGALS9; the disease is breast carcinoma.